Summit Therapeutics Ownership 2024 | Who Owns Summit Therapeutics Now?


OverviewForecastFinancialsChartTranscripts

Institutional Ownership

10.21%

Insider Ownership

84.36%

Retail Ownership

5.43%

Institutional Holders

124.00

Summit Therapeutics Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BAKER BROS. ADVISORS LP3.31%2.31%23,222,22223,222,222100.00%181,133,332Jun 30, 2024
VANGUARD GROUP INC1.26%0.00%8,818,4631,549,22021.31%68,784,012Jun 30, 2024
BLACKROCK INC.1.13%0.00%7,898,585-1,924,756-19.59%61,608,963Jun 30, 2024
FMR LLC1.08%0.00%7,565,427-409,104-5.13%59,010,330Jun 30, 2024
STATE STREET CORP0.59%0.00%4,123,137-3,991,093-49.19%32,160,469,000Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC0.42%0.00%2,963,827-188,563-5.98%23,122,403Jun 30, 2024
PRICE T ROWE ASSOCIATES INC /MD/0.29%0.00%2,042,1002,008,9556061.11%15,930,000Jun 30, 2024
MILLENNIUM MANAGEMENT LLC0.28%0.01%1,942,8581,942,858100.00%15,154,292Jun 30, 2024
BALYASNY ASSET MANAGEMENT L.P.0.14%0.01%1,010,1571,010,157100.00%7,879,225Jun 30, 2024
NORTHERN TRUST CORP0.14%0.00%960,303-112,411-10.48%7,490,363,000Jun 30, 2024
ANSON FUNDS MANAGEMENT LP0.13%0.88%941,908941,908100.00%7,346,882Jun 30, 2024
CHARLES SCHWAB INVESTMENT MANAGEMENT INC0.13%0.00%934,729-81,816-8.05%7,290,886Jun 30, 2024
FIRST TRUST ADVISORS LP0.11%0.01%788,067788,067100.00%6,146,922Jun 30, 2024
CAPTION MANAGEMENT, LLC0.10%0.09%723,700723,700100.00%5,644,860Jun 30, 2024
PICTET ASSET MANAGEMENT HOLDING SA0.10%0.01%708,623698,5606941.87%5,527,259Jun 30, 2024
QVT FINANCIAL LP0.08%0.42%575,705575,705100.00%4,490,499Jun 30, 2024
FEDERATED HERMES, INC.0.08%0.01%544,877-6,892-1.25%4,250,041,000Jun 30, 2024
CAPTION MANAGEMENT, LLC0.07%0.06%499,100499,100100.00%3,892,980Jun 30, 2024
GOLDMAN SACHS GROUP INC0.06%0.00%453,944-226,657-33.30%3,540,763Jun 30, 2024
BARCLAYS PLC0.06%0.00%387,313-5,999-1.53%3,021,000Jun 30, 2024

Summit Therapeutics's largest institutional shareholder is BAKER BROS. ADVISORS LP, holding 3.31% of the company's total share outstanding, currently valued at $181.13M. The top 10 institutional shareholders own together 8.63% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BAKER BROS. ADVISORS LP3.31%2.31%23,222,22223,222,222100.00%181,133,332Jun 30, 2024
ANSON FUNDS MANAGEMENT LP0.13%0.88%941,908941,908100.00%7,346,882Jun 30, 2024
QVT FINANCIAL LP0.08%0.42%575,705575,705100.00%4,490,499Jun 30, 2024
WEALTH MANAGEMENT PARTNERS, LLC0.01%0.16%42,000-2,000-4.55%327,600Jun 30, 2024
PINPOINT ASSET MANAGEMENT LTD0.02%0.13%120,746120,746100.00%941,819Jun 30, 2024
VANCE WEALTH, INC.0.01%0.13%39,266--306,275Jun 30, 2024
SARGENT INVESTMENT GROUP, LLC0.01%0.11%72,00062,000620.00%561,600Jun 30, 2024
CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD.0.01%0.09%82,473-52,372-38.84%643,289Jun 30, 2024
CAPTION MANAGEMENT, LLC0.10%0.09%723,700723,700100.00%5,644,860Jun 30, 2024
SECTORAL ASSET MANAGEMENT INC0.00%0.08%25,000-290,000-92.06%195,000Jun 30, 2024
CAPTION MANAGEMENT, LLC0.07%0.06%499,100499,100100.00%3,892,980Jun 30, 2024
FULLCIRCLE WEALTH LLC0.00%0.06%12,20912,209100.00%121,846Jun 30, 2024
HOYLECOHEN, LLC0.01%0.05%86,4082,0002.37%673,983Jun 30, 2024
VIRTUS ETF ADVISERS LLC0.00%0.04%11,190-21,625-65.90%87,282Jun 30, 2024
ALPINE GLOBAL MANAGEMENT, LLC0.00%0.04%29,149-5,851-16.72%227,362Jun 30, 2024
LEVIN CAPITAL STRATEGIES, L.P.0.01%0.03%39,176--305,573Jun 30, 2024
WORLD EQUITY GROUP, INC.0.00%0.03%12,7791531.21%99,676Jun 30, 2024
BLANKINSHIP & FOSTER, LLC0.00%0.03%12,777--99,661Jun 30, 2024
BENDER ROBERT & ASSOCIATES0.00%0.02%14,05914,059100.00%109,660Jun 30, 2024
FPC INVESTMENT ADVISORY, INC.0.00%0.02%1,946--18,118Jun 30, 2024

The largest Summit Therapeutics shareholder by % of total assets is BAKER BROS. ADVISORS LP. The company owns 23.22M shares of Summit Therapeutics (SMMT), representing 2.31% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BAKER BROS. ADVISORS LP3.31%2.31%23,222,22223,222,222100.00%181,133,332Jun 30, 2024
PRICE T ROWE ASSOCIATES INC /MD/0.29%0.00%2,042,1002,008,9556061.11%15,930,000Jun 30, 2024
MILLENNIUM MANAGEMENT LLC0.28%0.01%1,942,8581,942,858100.00%15,154,292Jun 30, 2024
VANGUARD GROUP INC1.26%0.00%8,818,4631,549,22021.31%68,784,012Jun 30, 2024
BALYASNY ASSET MANAGEMENT L.P.0.14%0.01%1,010,1571,010,157100.00%7,879,225Jun 30, 2024
ANSON FUNDS MANAGEMENT LP0.13%0.88%941,908941,908100.00%7,346,882Jun 30, 2024
FIRST TRUST ADVISORS LP0.11%0.01%788,067788,067100.00%6,146,922Jun 30, 2024
CAPTION MANAGEMENT, LLC0.10%0.09%723,700723,700100.00%5,644,860Jun 30, 2024
PICTET ASSET MANAGEMENT HOLDING SA0.10%0.01%708,623698,5606941.87%5,527,259Jun 30, 2024
QVT FINANCIAL LP0.08%0.42%575,705575,705100.00%4,490,499Jun 30, 2024
CAPTION MANAGEMENT, LLC0.07%0.06%499,100499,100100.00%3,892,980Jun 30, 2024
TD ASSET MANAGEMENT INC0.04%0.00%266,800266,800100.00%2,081,040Jun 30, 2024
VOYA INVESTMENT MANAGEMENT LLC0.04%0.00%257,046217,580551.31%2,004,959Jun 30, 2024
ALLIANCEBERNSTEIN L.P.0.04%0.00%308,576186,566152.91%2,406,893Jun 30, 2024
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP0.02%0.00%141,680141,680100.00%1,105,000Jun 30, 2024
VOLORIDGE INVESTMENT MANAGEMENT, LLC0.02%0.00%140,577140,577100.00%1,096,501Jun 30, 2024
MANUFACTURERS LIFE INSURANCE COMPANY, THE0.03%0.00%206,057128,934167.18%1,607,245Jun 30, 2024
PINPOINT ASSET MANAGEMENT LTD0.02%0.13%120,746120,746100.00%941,819Jun 30, 2024
SIMPLEX TRADING, LLC0.02%0.00%114,647114,647100.00%894,000Jun 30, 2024
HUDSON BAY CAPITAL MANAGEMENT LP0.01%0.00%75,00075,000100.00%585,000Jun 30, 2024

As of Jun 30 2024, Summit Therapeutics's largest institutional buyer is BAKER BROS. ADVISORS LP. The company purchased 23.22M stocks of SMMT, valued at $181.13M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
STATE STREET CORP0.59%0.00%4,123,137-3,991,093-49.19%32,160,469,000Jun 30, 2024
BLACKROCK INC.1.13%0.00%7,898,585-1,924,756-19.59%61,608,963Jun 30, 2024
STEWARD PARTNERS INVESTMENT ADVISORY, LLC----606,500-100.00%-Jun 30, 2024
BANK OF MONTREAL /CAN/----589,566-100.00%-Jun 30, 2024
ALPS ADVISORS INC----494,924-100.00%-Jun 30, 2024
RAFFERTY ASSET MANAGEMENT, LLC0.02%0.00%165,898-484,388-74.49%1,294,004Jun 30, 2024
FMR LLC1.08%0.00%7,565,427-409,104-5.13%59,010,330Jun 30, 2024
MORGAN STANLEY0.05%0.00%337,117-355,424-51.32%2,629,512Jun 30, 2024
UBS GROUP AG0.02%0.00%167,867-309,075-64.80%1,309,363Jun 30, 2024
SECTORAL ASSET MANAGEMENT INC0.00%0.08%25,000-290,000-92.06%195,000Jun 30, 2024
SWISS NATIONAL BANK----275,000-100.00%-Jun 30, 2024
GOLDMAN SACHS GROUP INC0.06%0.00%453,944-226,657-33.30%3,540,763Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC0.42%0.00%2,963,827-188,563-5.98%23,122,403Jun 30, 2024
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM0.00%0.00%6,343-131,303-95.39%49,475Jun 30, 2024
UBS ASSET MANAGEMENT AMERICAS INC----114,592-100.00%-Jun 30, 2024
NORTHERN TRUST CORP0.14%0.00%960,303-112,411-10.48%7,490,363,000Jun 30, 2024
STATE OF WISCONSIN INVESTMENT BOARD----102,394-100.00%-Jun 30, 2024
NUVEEN ASSET MANAGEMENT, LLC0.04%0.00%276,692-93,233-25.20%2,158,198Jun 30, 2024
LEGAL & GENERAL GROUP PLC0.00%-28,233-89,385-76.00%220,076Jun 30, 2024
JPMORGAN CHASE & CO0.02%0.00%163,750-85,917-34.41%1,277,250Jun 30, 2024

As of Jun 30 2024, Summit Therapeutics's biggest institutional seller is STATE STREET CORP. The company sold -3.99M shares of SMMT, valued at $32.16B.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BAKER BROS. ADVISORS LP3.31%2.31%23,222,22223,222,222100.00%181,133,332Jun 30, 2024
MILLENNIUM MANAGEMENT LLC0.28%0.01%1,942,8581,942,858100.00%15,154,292Jun 30, 2024
BALYASNY ASSET MANAGEMENT L.P.0.14%0.01%1,010,1571,010,157100.00%7,879,225Jun 30, 2024
ANSON FUNDS MANAGEMENT LP0.13%0.88%941,908941,908100.00%7,346,882Jun 30, 2024
CAPTION MANAGEMENT, LLC0.10%0.09%723,700723,700100.00%5,644,860Jun 30, 2024
QVT FINANCIAL LP0.08%0.42%575,705575,705100.00%4,490,499Jun 30, 2024
CAPTION MANAGEMENT, LLC0.07%0.06%499,100499,100100.00%3,892,980Jun 30, 2024
TD ASSET MANAGEMENT INC0.04%0.00%266,800266,800100.00%2,081,040Jun 30, 2024
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP0.02%0.00%141,680141,680100.00%1,105,000Jun 30, 2024
VOLORIDGE INVESTMENT MANAGEMENT, LLC0.02%0.00%140,577140,577100.00%1,096,501Jun 30, 2024
PINPOINT ASSET MANAGEMENT LTD0.02%0.13%120,746120,746100.00%941,819Jun 30, 2024
SIMPLEX TRADING, LLC0.02%0.00%114,647114,647100.00%894,000Jun 30, 2024
HUDSON BAY CAPITAL MANAGEMENT LP0.01%0.00%75,00075,000100.00%585,000Jun 30, 2024
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD.0.01%0.00%64,81864,818100.00%506,018Jun 30, 2024
HANDELSBANKEN FONDER AB0.01%0.00%63,90063,900100.00%498,000Jun 30, 2024
AQR CAPITAL MANAGEMENT LLC0.01%0.00%62,11462,114100.00%484,490Jun 30, 2024
LMR PARTNERS LLP0.01%0.00%50,00050,000100.00%390,000Jun 30, 2024
COREBRIDGE FINANCIAL, INC.0.01%0.00%47,09747,097100.00%367,357Jun 30, 2024
OMERS ADMINISTRATION CORP0.01%0.00%35,50035,500100.00%276,900Jun 30, 2024
WOLVERINE TRADING, LLC0.00%0.00%32,80032,800100.00%255,840Jun 30, 2024
BREVAN HOWARD CAPITAL MANAGEMENT LP0.00%0.00%31,21431,214100.00%243,469Jun 30, 2024
D. E. SHAW & CO., INC.0.00%0.00%29,70029,700100.00%231,660Jun 30, 2024
CENTIVA CAPITAL, LP0.00%0.00%29,22529,225100.00%227,955Jun 30, 2024
PALOMA PARTNERS MANAGEMENT CO0.00%0.01%28,40028,400100.00%221,520Jun 30, 2024
COWEN AND COMPANY, LLC0.00%0.00%25,00025,000100.00%47,499Jun 30, 2024
SCHONFELD STRATEGIC ADVISORS LLC0.00%0.00%21,91921,919100.00%170,968Jun 30, 2024
ALLIANZ ASSET MANAGEMENT GMBH0.00%0.00%19,95319,953100.00%155,633Jun 30, 2024
CIBC ASSET MANAGEMENT INC0.00%0.00%19,70519,705100.00%153,699Jun 30, 2024
GOTHAM ASSET MANAGEMENT, LLC0.00%0.00%19,50019,500100.00%152,100Jun 30, 2024
SVB WEALTH LLC0.00%0.00%17,15017,150100.00%133,770Jun 30, 2024
BAYESIAN CAPITAL MANAGEMENT, LP0.00%0.01%16,49916,499100.00%128,692Jun 30, 2024
XTX TOPCO LTD0.00%0.01%15,50015,500100.00%120,900Jun 30, 2024
BENDER ROBERT & ASSOCIATES0.00%0.02%14,05914,059100.00%109,660Jun 30, 2024
WOLVERINE TRADING, LLC0.00%0.00%12,70012,700100.00%99,060Jun 30, 2024
FULLCIRCLE WEALTH LLC0.00%0.06%12,20912,209100.00%121,846Jun 30, 2024
CREATIVEONE WEALTH, LLC0.00%0.00%11,60011,600100.00%90,000Jun 30, 2024
QUINN OPPORTUNITY PARTNERS LLC0.00%0.01%11,00011,000100.00%85,800Jun 30, 2024
WOLVERINE TRADING, LLC0.00%0.00%10,58010,580100.00%82,524Jun 30, 2024
CSS LLC/IL0.00%0.00%2,0002,000100.00%15,600Jun 30, 2024
MACQUARIE GROUP LTD0.00%-1,2741,274100.00%9,937Jun 30, 2024
SRS CAPITAL ADVISORS, INC.0.00%0.00%1,0191,019100.00%7,949Jun 30, 2024
TWIN TREE MANAGEMENT, LP0.00%-471471100.00%3,674Jun 30, 2024
PNC FINANCIAL SERVICES GROUP, INC.--4545100.00%351Jun 30, 2024
ALLWORTH FINANCIAL LP--2222100.00%194Jun 30, 2024

Summit Therapeutics's largest new institutional shareholder by number of shares is BAKER BROS. ADVISORS LP, purchased 23.22M shares, valued at $181.13M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
STEWARD PARTNERS INVESTMENT ADVISORY, LLC----606,500-100.00%-Jun 30, 2024
BANK OF MONTREAL /CAN/----589,566-100.00%-Jun 30, 2024
ALPS ADVISORS INC----494,924-100.00%-Jun 30, 2024
SWISS NATIONAL BANK----275,000-100.00%-Jun 30, 2024
UBS ASSET MANAGEMENT AMERICAS INC----114,592-100.00%-Jun 30, 2024
STATE OF WISCONSIN INVESTMENT BOARD----102,394-100.00%-Jun 30, 2024
JANUS HENDERSON GROUP PLC----76,590-100.00%-Jun 30, 2024
AMERICAN INTERNATIONAL GROUP, INC.----57,108-100.00%-Jun 30, 2024
ARIZONA STATE RETIREMENT SYSTEM----38,522-100.00%-Jun 30, 2024
BOOTHBAY FUND MANAGEMENT, LLC----35,000-100.00%-Jun 30, 2024
TEACHER RETIREMENT SYSTEM OF TEXAS----31,203-100.00%-Jun 30, 2024
GROUP ONE TRADING, L.P.----30,019-100.00%-Jun 30, 2024
OXFORD ASSET MANAGEMENT LLP----27,080-100.00%-Jun 30, 2024
ENTRYPOINT CAPITAL, LLC----24,186-100.00%-Jun 30, 2024
TWO SIGMA INVESTMENTS, LP----23,579-100.00%-Jun 30, 2024
JUMP FINANCIAL, LLC----22,462-100.00%-Jun 30, 2024
VIRTU FINANCIAL LLC----20,372-100.00%-Jun 30, 2024
GRAHAM CAPITAL MANAGEMENT, L.P.----18,961-100.00%-Jun 30, 2024
METROPOLITAN LIFE INSURANCE CO/NY----6,561-100.00%-Jun 30, 2024

Summit Therapeutics's largest sold out institutional shareholder by shares sold is STEWARD PARTNERS INVESTMENT ADVISORY, LLC, sold -0.61M shares, valued at -, as of undefined.

Summit Therapeutics Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
VANGUARD VALLEY FORGE FUNDS0.15%77,925--Mar 31, 2024
Humankind Benefit Corp0.15%3,275-353-9.73%Dec 31, 2023
FIDELITY SELECT PORTFOLIOS0.08%5,354,3295,354,329-Feb 29, 2024
FIDELITY COMMONWEALTH TRUST0.08%241,3203,9371.66%Feb 29, 2024
VARIABLE INSURANCE PRODUCTS FUND IV0.05%140,000140,000-Mar 31, 2024
ALPS ETF Trust0.05%574,67381,84516.61%Feb 29, 2024
FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND0.04%165,119--Jan 31, 2024
QUANTITATIVE MASTER SERIES LLC0.03%206,165-11,082-5.10%Mar 31, 2024
BRIDGEWAY FUNDS INC0.03%76,500--Mar 28, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.03%18,036--Mar 31, 2024
Federated Hermes Equity Funds0.03%537,522537,522-Jan 31, 2024
FIDELITY MT VERNON STREET TRUST0.03%742,100742,100-Feb 29, 2024
Nushares ETF Trust0.02%167,317167,317-Jan 31, 2024
ETFis Series Trust I0.02%31,085-19,629-38.71%Jan 31, 2024
VANGUARD INDEX FUNDS0.01%5,550,122-1,778,584-24.27%Mar 31, 2024
FIDELITY ADVISOR SERIES VII0.01%77,61677,616-Jan 31, 2024
SCHWAB CAPITAL TRUST0.01%311,3282580.08%Jan 31, 2024
FIDELITY CONCORD STREET TRUST0.01%1,524,42453,2193.62%Feb 29, 2024
Fidelity Central Investment Portfolios LLC0.01%280,000280,000-Mar 31, 2024
TIAA SEPARATE ACCOUNT VA 10.00%998-9,165-90.18%Mar 31, 2024
Calvert Variable Products, Inc.0.00%11,6192,05021.42%Mar 31, 2024
ETF Series Solutions0.00%88,21014,13819.09%Feb 29, 2024
FIDELITY COVINGTON TRUST0.00%71,567-1,140-1.57%Jan 31, 2024
VARIABLE INSURANCE PRODUCTS FUND0.00%68,00068,000-Mar 31, 2024
ProFunds0.00%33,91432,9393378.36%Mar 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%70,842-5,088-6.70%Mar 31, 2024
VANGUARD WORLD FUND0.00%474,706474,706-Feb 29, 2024
FEDERATED HERMES INSURANCE SERIES0.00%7,3557,355-Mar 31, 2024
Voya VARIABLE PORTFOLIOS INC0.00%39,466-8,567-17.84%Mar 31, 2024
SCHWAB STRATEGIC TRUST0.00%669,14230,9604.85%Feb 29, 2024
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%5,177-1,511-22.59%Mar 31, 2024
CLEARWATER INVESTMENT TRUST0.00%9,4339,433-Mar 28, 2024
Federated Hermes Global Allocation Fund0.00%7,738-4,880-38.67%Feb 29, 2024
AMERICAN CENTURY ETF TRUST0.00%76,77040,147109.62%Feb 29, 2024
TIAA-CREF LIFE FUNDS0.00%1,773--Mar 31, 2024
GPS Funds I0.00%3,379--Mar 31, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%40,100--Mar 31, 2024
RUSSELL INVESTMENT CO0.00%160,549--Jan 31, 2024
NORTHERN FUNDS0.00%51,8403610.70%Mar 28, 2024
T. Rowe Price Index Trust, Inc.0.00%7,2264716.97%Mar 31, 2024
iSHARES TRUST0.00%4,936,987-339,583-6.44%Mar 31, 2024
FLEXSHARES TRUST0.00%23,24023,240-Jan 31, 2024
VANGUARD WELLINGTON FUND0.00%115,35829,26233.99%Feb 29, 2024
PROSHARES TRUST0.00%69,3429,87516.61%Feb 29, 2024
ALLSPRING MASTER TRUST0.00%17,333--Feb 29, 2024
VANGUARD SCOTTSDALE FUNDS0.00%534,42366,33814.17%Feb 29, 2024
RYDEX SERIES FUNDS0.00%1,058--Dec 31, 2023
EQ ADVISORS TRUST0.00%293,149-11,919-3.91%Mar 31, 2024
HC CAPITAL TRUST0.00%7,383--Mar 31, 2024
SPDR INDEX SHARES FUNDS0.00%31,682--Mar 31, 2024
VALIC Co I0.00%44,470-180-0.40%Feb 29, 2024
NATIONWIDE MUTUAL FUNDS0.00%20,1007713.99%Jan 31, 2024
J.P. Morgan Exchange-Traded Fund Trust0.00%69,79469,794-Jan 31, 2024
SPDR SERIES TRUST0.00%5,417,8485,417,848-Mar 31, 2024
PENN SERIES FUNDS INC0.00%3,800-600-13.64%Mar 28, 2024
RYDEX DYNAMIC FUNDS0.00%524--Dec 31, 2023
NATIONWIDE VARIABLE INSURANCE TRUST0.00%17,218--Mar 31, 2024
TIAA-CREF FUNDS0.00%320,060--Jan 31, 2024
FIDELITY CONCORD STREET TRUST0.00%19,411--Feb 29, 2024
Invesco Exchange-Traded Fund Trust II0.00%18,9886,81355.96%Feb 29, 2024
RYDEX VARIABLE TRUST0.00%69--Dec 31, 2023
COLLEGE RETIREMENT EQUITIES FUND0.00%57,751--Mar 31, 2024
USAA MUTUAL FUNDS TRUST0.00%12,267--Jan 31, 2024
Brighthouse Funds Trust II0.00%40,272--Mar 31, 2024
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST0.00%98,100--Mar 31, 2024
MORGAN STANLEY PATHWAY FUNDS0.00%3,907--Feb 29, 2024
Invesco Exchange-Traded Self-Indexed Fund Trust0.00%8,399--Feb 29, 2024
SUNAMERICA SERIES TRUST0.00%13,128-53-0.40%Jan 31, 2024
Brinker Capital Destinations Trust0.00%2,119--Feb 29, 2024
Guggenheim Active Allocation Fund0.00%157--Feb 29, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST0.00%53,987-399-0.73%Mar 31, 2024
FIDELITY SALEM STREET TRUST0.00%57,4527,09214.08%Mar 31, 2024
TRUST FOR PROFESSIONAL MANAGERS0.00%3,313--Feb 29, 2024
PACIFIC SELECT FUND0.00%37,162-473-1.26%Mar 31, 2024
Bridge Builder Trust0.00%22,1791,5597.56%Mar 31, 2024
BLACKROCK FUNDS0.00%21,835--Jan 31, 2024
BlackRock Variable Series Funds, Inc.0.00%14,196--Mar 31, 2024
PRINCIPAL FUNDS, INC.0.00%14,5482,46420.39%Jan 31, 2024
MASSMUTUAL SELECT FUNDS0.00%2,319--Dec 31, 2023
SEI INSTITUTIONAL INVESTMENTS TRUST0.00%30,80026,000541.67%Feb 29, 2024

Summit Therapeutics's largest mutual fund holder by % of total assets is "VANGUARD VALLEY FORGE FUNDS", owning 77.92K shares, compromising 0.15% of its total assets.

Summit Therapeutics Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 2412416.98%
31 Mar, 241069.28%
31 Dec, 23973.19%
30 Sep, 2394-7.84%
30 Jun, 231023.03%
31 Mar, 239959.68%
31 Dec, 226255.00%
30 Sep, 224014.29%
30 Jun, 2235-23.91%
31 Mar, 2246-14.81%
31 Dec, 2154-
30 Sep, 2154-6.90%
30 Jun, 215856.76%
31 Mar, 213715.63%
31 Dec, 2032100.00%
30 Sep, 2016-

As of 30 Jun 24, 124 institutions are holding Summit Therapeutics's shares, representing an increase of 16.98% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 2471,635,99544.31%
31 Mar, 2449,642,03954.58%
31 Dec, 2332,113,817-0.21%
30 Sep, 2332,181,292-7.57%
30 Jun, 2334,817,56665.75%
31 Mar, 2321,005,698160.56%
31 Dec, 228,061,878153.75%
30 Sep, 223,177,060-62.44%
30 Jun, 228,459,429-23.11%
31 Mar, 2211,002,695-0.88%
31 Dec, 2111,100,5850.83%
30 Sep, 2111,009,449-0.63%
30 Jun, 2111,079,08819.35%
31 Mar, 219,283,2202.44%
31 Dec, 209,062,39116.94%
30 Sep, 207,749,622-

Summit Therapeutics (SMMT) has 71.64M shares outstanding as of 30 Jun 24, up 44.31% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 2410.21%15.90%
31 Mar, 248.01%37.82%
31 Dec, 234.60%21.63%
30 Sep, 234.61%5.44%
30 Jun, 239.21%29.84%
31 Mar, 235.55%31.95%
31 Dec, 224.17%91.20%
30 Sep, 222.14%2.97%
30 Jun, 228.49%6.74%
31 Mar, 2211.22%8.53%
31 Dec, 2111.47%8.99%
30 Sep, 2111.30%7.56%
30 Jun, 2112.22%9.73%
31 Mar, 2111.21%6.60%
31 Dec, 2013.03%10.06%
30 Sep, 2011.38%-

As of 30 Jun 24, Summit Therapeutics is held by 10.21% institutional shareholders, representing a 15.90% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 24603.45%
31 Mar, 245828.89%
31 Dec, 23457.14%
30 Sep, 2342-28.81%
30 Jun, 2359-7.81%
31 Mar, 236452.38%
31 Dec, 224268.00%
30 Sep, 222556.25%
30 Jun, 2216-11.11%
31 Mar, 2218-18.18%
31 Dec, 2122-31.25%
30 Sep, 2132-23.81%
30 Jun, 214282.61%
31 Mar, 2123-11.54%
31 Dec, 202662.50%
30 Sep, 2016-

60 institutional shareholders have increased their position in SMMT stock as of 30 Jun 24 compared to 58 in the previous quarter (a 3.45% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 244573.08%
31 Mar, 242636.84%
31 Dec, 2319-
30 Sep, 2319-9.52%
30 Jun, 232150.00%
31 Mar, 2314100.00%
31 Dec, 22740.00%
30 Sep, 225-64.29%
30 Jun, 2214-17.65%
31 Mar, 2217-15.00%
31 Dec, 212053.85%
30 Sep, 211330.00%
30 Jun, 211042.86%
31 Mar, 217133.33%
31 Dec, 203-
30 Sep, 20--

45 institutional shareholders have reduced their position in SMMT stock as of 30 Jun 24 compared to 26 in the previous quarter (a 73.08% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 2412416.98%71,635,99544.31%10.21%15.90%603.45%4573.08%
31 Mar, 241069.28%49,642,03954.58%8.01%37.82%5828.89%2636.84%
31 Dec, 23973.19%32,113,817-0.21%4.60%21.63%457.14%19-
30 Sep, 2394-7.84%32,181,292-7.57%4.61%5.44%42-28.81%19-9.52%
30 Jun, 231023.03%34,817,56665.75%9.21%29.84%59-7.81%2150.00%
31 Mar, 239959.68%21,005,698160.56%5.55%31.95%6452.38%14100.00%
31 Dec, 226255.00%8,061,878153.75%4.17%91.20%4268.00%740.00%
30 Sep, 224014.29%3,177,060-62.44%2.14%2.97%2556.25%5-64.29%
30 Jun, 2235-23.91%8,459,429-23.11%8.49%6.74%16-11.11%14-17.65%
31 Mar, 2246-14.81%11,002,695-0.88%11.22%8.53%18-18.18%17-15.00%
31 Dec, 2154-11,100,5850.83%11.47%8.99%22-31.25%2053.85%
30 Sep, 2154-6.90%11,009,449-0.63%11.30%7.56%32-23.81%1330.00%
30 Jun, 215856.76%11,079,08819.35%12.22%9.73%4282.61%1042.86%
31 Mar, 213715.63%9,283,2202.44%11.21%6.60%23-11.54%7133.33%
31 Dec, 2032100.00%9,062,39116.94%13.03%10.06%2662.50%3-
30 Sep, 2016-7,749,622-11.38%-16---

Summit Therapeutics Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Mar 27, 2024Zanganeh Mahkamdirector, officer Chief Executive OfficerP-PurchaseBuy34,321$3.72$127.67K24,923,800
Mar 27, 2024Zanganeh Mahkamdirector, officer Chief Executive OfficerP-PurchaseBuy26,000$3.72$96.72K520,814
Mar 27, 2024Zanganeh Mahkamdirector, officer Chief Executive OfficerP-PurchaseBuy20,000$3.71$74.20K50,000
Mar 27, 2024Zanganeh Mahkamdirector, officer Chief Executive OfficerP-PurchaseBuy30,000$3.75$112.50K30,000
Mar 27, 2024Dhingra Ankurofficer Chief Financial OfficerP-PurchaseBuy100,000$3.75$375.00K354,958

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Mar 27, 2024Zanganeh Mahkamdirector, officer Chief Executive OfficerP-PurchaseBuy34,321$3.72$127.67K24,923,800
Mar 27, 2024Zanganeh Mahkamdirector, officer Chief Executive OfficerP-PurchaseBuy26,000$3.72$96.72K520,814
Mar 27, 2024Zanganeh Mahkamdirector, officer Chief Executive OfficerP-PurchaseBuy20,000$3.71$74.20K50,000
Mar 27, 2024Zanganeh Mahkamdirector, officer Chief Executive OfficerP-PurchaseBuy30,000$3.75$112.50K30,000
Mar 27, 2024Dhingra Ankurofficer Chief Financial OfficerP-PurchaseBuy100,000$3.75$375.00K354,958

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Apr 04, 2024Anand Bhaskarofficer Chief Accounting OfficerSell---109,400

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jun 27, 2024Huber Jeffdirector-A-AwardBuy17,883$7.87$140.74K217,883
Jun 27, 2024Huber Jeffdirector-A-AwardBuy200,000$7.87$1.57M200,000
Jun 27, 2024Huber Jeffdirector-Buy---6,000
Apr 15, 2024Ronaghi Mostafadirector-A-AwardBuy25,315$4.03$102.02K225,315
Apr 15, 2024Ronaghi Mostafadirector-A-AwardBuy200,000$4.03$806.00K200,000
Apr 15, 2024Ronaghi Mostafadirector Buy----
Apr 04, 2024Soni Manmeet Singhdirector, officer Chief Operating OfficerA-AwardBuy1,100,000$3.85$4.24M1,100,000
Apr 04, 2024Anand Bhaskarofficer Chief Accounting OfficerA-AwardBuy600,000$3.85$2.31M600,000
Apr 04, 2024Anand Bhaskarofficer Chief Accounting OfficerSell---109,400
Mar 27, 2024Zanganeh Mahkamdirector, officer Chief Executive OfficerP-PurchaseBuy34,321$3.72$127.67K24,923,800
Mar 27, 2024Zanganeh Mahkamdirector, officer Chief Executive OfficerP-PurchaseBuy26,000$3.72$96.72K520,814
Mar 27, 2024Zanganeh Mahkamdirector, officer Chief Executive OfficerP-PurchaseBuy20,000$3.71$74.20K50,000
Mar 27, 2024Zanganeh Mahkamdirector, officer Chief Executive OfficerP-PurchaseBuy30,000$3.75$112.50K30,000
Mar 27, 2024Dhingra Ankurofficer Chief Financial OfficerP-PurchaseBuy100,000$3.75$375.00K354,958
Feb 14, 2024Xia Yudirector Buy----
Jan 04, 2024Cesano Alessandradirector-A-AwardBuy21,363$2.64$56.40K56,363
Jan 04, 2024Cesano Alessandradirector-A-AwardBuy35,000$2.64$92.40K35,000
Jan 04, 2024Booth Robert F.director-A-AwardBuy47,651$2.64$125.80K82,651
Jan 04, 2024Booth Robert F.director-A-AwardBuy35,000$2.64$92.40K35,000
Jan 04, 2024Clark Kenneth Adirector-A-AwardBuy70,492$2.64$186.10K105,492

The last insider sell of Summit Therapeutics's stock was made by Anand Bhaskar on Apr 04 2024, selling - shares at - per share (valued at -). The last insider buy of SMMT was made by Zanganeh Mahkam on Mar 27 2024, buying 34,321 shares at $3.72 per share (worth $127.67K).

Summit Therapeutics Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 202461600.00%
Q1 202416--
Q4 202382400.00%
Q1 202316--
Q4 20224--
Q3 20229--
Q2 202232150.00%
Q1 20228--
Q4 202191900.00%
Q2 20212--
Q1 202161600.00%
Q4 20201211109.09%
Q3 2020-17-
Q2 2020-2-

6 total buy trades, and 1 total sell trades (buy/sell ratio of 6.00%) were made by Summit Therapeutics's insiders, as of Q2 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024---
Q1 20245--
Q4 20234--
Q1 20237--
Q4 2022---
Q3 20227--
Q2 2022---
Q1 2022---
Q4 2021---
Q2 20212--
Q1 2021---
Q4 20201520.00%
Q3 2020---
Q2 2020---

As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Summit Therapeutics's stocks.

Summit Therapeutics Peer Ownership


TickerCompany
ZVSAZyVersa Therapeutics, Inc.
CGEMCullinan Oncology, Inc.
PHIOPhio Pharmaceuticals Corp.
KRONKronos Bio, Inc.
OCEAOcean Biomedical, Inc.
NKTXNkarta, Inc.
SONNSonnet BioTherapeutics Holdings, Inc.
KZRKezar Life Sciences, Inc.
ZURAZura Bio Limited
ELEVElevation Oncology, Inc.
CDIOCardio Diagnostics Holdings, Inc.
ATNF180 Life Sciences Corp.

SMMT Ownership FAQ


Summit Therapeutics is owned by institutional shareholders (10.21%), insiders (84.36%), and public (5.43%). The largest institutional shareholder of Summit Therapeutics is BAKER BROS. ADVISORS LP (3.31% of total shares) and the top mutual fund owner is VANGUARD VALLEY FORGE FUNDS (0.15% of total shares).

Summit Therapeutics's major institutional shareholders are BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, BLACKROCK INC., FMR LLC, and STATE STREET CORP. The top five shareholders own together 7.36% of the company's share outstanding.

As of Jun 2024, there are 124 institutional shareholders of Summit Therapeutics.

BAKER BROS. ADVISORS LP owns 23.22M shares of Summit Therapeutics, representing 3.31% of the company's total shares outstanding, valued at $181.13M (as of Jun 2024).

As of Jun 2024, VANGUARD GROUP INC holds 8.82M shares of Summit Therapeutics (SMMT), compromising 1.26% of the company, valued at $68.78M.

BLACKROCK INC is the third largest holder of Summit Therapeutics. The company owns 7.9M of the company's shares outstanding (worth $61.61M).